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Abstract
DNA interstrand cross-links are a form of genomic damage that cause a block to
replication and transcription of DNA in cells and cause lethality if unrepaired. Chemical
agents that induce cross-links are particularly effective at inactivating rapidly dividing
cells and, because of this, have been used to treat hyperproliferative skin disorders such
as psoriasis as well as a variety of cancers. However, evidence for the removal of crosslinks from DNA as well as resistance to cross-link-based chemotherapy suggests the
existence of a cellular repair mechanism. Characterizing the pathways involved in DNA
interstrand cross-link repair has been challenging due to the inherent structure of the
damage as it precludes the use of an undamaged, complementary strand of DNA as a
template for repair.
A number of models of cross-link repair have been proposed based on the
identification of hypersensitive repair mutants as well as biochemical evidence that
specific repair enzymes are capable of incising cross-linked structures from DNA.
Together, these models have suggested the involvement of multiple repair pathways—
such as nucleotide exicision repair, translesion synthesis, recombination of double-strand
breaks, and base excision repair—operating in sequential steps to correct the damage.
Most of the studies from which these models arose are complicated by the fact that crosslinking agents induce multiple forms of damage or they lack in vivo confirmation of how
the repair phenomenon occurs in organisms.
In this study, I use Escherichia coli as a model organism to examine the involvement
of the aforementioned pathways in DNA interstrand cross-link repair in vivo. This
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organism was useful in early cross-link studies and, with its highly conserved repair
processes, maintains the potential for delineating how cross-links are removed in higher
organisms. In Chapter I, I introduce background information on different cross-linking
agents, the complications of studying cross-link repair, and the candidate repair pathways
that have been implicated to date.
In Chapter II I demonstrate that there is a limited involvement of the nucleotide
excision repair helicase, translesion polymerases, and double-strand break repair enzymes
through survival analysis of cells defective in these proteins. For this analysis, I use 8methoxypsoralen plus UVA as a cross-linking agent and angelicin plus UVA as a
monofunctional comparator. The observation that uvrD mutants—defective in helicase II
of nucleotide excision repair—were nearly as resistant to 8-methoxypsoralen-induced
damage as wild type cells led me to examine the incision rate of cross-links from
endogenous plasmid DNA. Surprisingly, cross-links were not efficiently removed from
DNA in uvrD mutants relative to wild type cells. These seemingly contradictory results
were rectified when I quantified cross-link formation in cell cultures and revealed that as
few as one cross-link per chromosome can inactive wild type cells, a lethal quantity that
is lower than what has been previously reported. Taken together, these observations
suggest that although cross-links are incised in wild type cells, repair is still not a highly
productive event in E. coli.
In Chapter III I examine the involvement of the base excision repair pathway in crosslink repair and demonstrate that Nth and Fpg Glycosylases, Xth and Nfo APEndonucleases sensitize Escherichia coli to psoralen-induced DNA damage. This is
shown by comparative survival analysis in angelicin plus UVA and 8-methoxypsoralen

iii
plus UVA treatment whereby nth-, fpg-, and xth-mutants are each more resistant than
wild type cells to either treatment. This suggests that when these gene products are
present they impact the production or removal of monoadducts. nfo-mutants were
different in that the cells were only hyperresistant to 8-methoxypsoralen monoadducts
and cross-links, either implying that the Nfo enzyme interacts specifically with psoralen
monoadducts rather than angelicin monoadducts or that the enzyme impedes cross-link
removal.
Finally, in Chapter IV a summary of the results is provided as well as future
directions that may be explored following this study.
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Chapter I: Introduction

DNA interstrand cross-links form when chemicals covalently bind
complementary strands of DNA. This type of damage obstructs necessary cellular
processes such as replication and transcription and is lethal if left unrepaired. Knowledge
of cross-linking agents came out of studies that examined the effects of mustard gas and
nitrogen mustard employed during the World Wars (1, 2). It was observed that these
compounds were particularly detrimental to actively dividing cells, such as those found in
tumors of mice (3). This finding led to the use of nitrogen mustard as a chemotherapeutic
in humans years before the actual mechanism of action was determined to be crosslinking of DNA (3–5). Interestingly, secondary malignancies can arise from the use of
cross-linking agents in chemotherapy (6, 7). For most, this risk following treatment does
not outweigh the benefit. However, for a small population cross-linking agents cannot be
repaired and therefore treatment itself can be lethal.
The population that this risk applies to is those afflicted with Fanconi anemia, a
rare genetic disorder characterized by bone marrow failure, high susceptibility to acute
myeloid leukemia, and diminished capacity for cross-link repair (8, 9). One method of
diagnosing this disorder involves a chromosome breakage test in which a blood sample is
treated with a cross-linking agent and then 72 hours later chromosomes at metaphase are
examined (10, 11). A positive result is indicated by major chromosomal aberrations,
which are consequences of cells that lack the gene products necessary to repair crosslinks (12).
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To date, 21 genes have been associated with the Fanconi anemia pathway (13),
yet a complete understanding of how these gene products operate in healthy cells is still
being delineated. The proteins identified in this pathway have been characterized by their
involvement with the monoubiquitination of a heterodimer complex formed by proteins
FANCD2 and FANCI. As such, there are proteins that comprise a core ubiquitin ligase
complex responsible for monoubiquitination of FANCI/D2 and proteins that are recruited
by this unbiquitinated heterodimer and act downstream to unhook cross-links from DNA
and restore the damaged DNA site (13, 14). The majority of those diagnosed with
Fanconi anemia have mutations in the core ubiquitin ligase complex (15), however, genes
associated with this pathway are still being identified (16) and the overall repair
mechanism of cross-links in humans is only partially understood.

DNA interstrand cross-linking agents
While there is considerable evidence for the removal of cross-links from DNA in
cells, how this form of damage is precisely repaired has remained challenging to
characterize. One problem with identifying a repair mechanism is that chemical agents
that form cross-links each have different binding (Figure 1.1) and structural effects on
DNA. For example, nitrogen mustard binds to guanine bases in 5’-GNC sequences and
severely distorts the beta structure of the DNA helix (17–20). Cisplatin preferentially
binds guanines in 5’-GC substrates and induces a major bend and minor unwinding in the
helical DNA structure. By comparison, mitomycin C binds to guanines in 5’-CG
sequences but does not significantly distort the helix (21–23). Psoralen—the crosslinking agent that is the focus of this study—binds to thymines at 5’-TA sites and only
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modestly distorts DNA upon intercalation and binding (24, 25). If cellular recognition of
damage is a prerequisite to repair then it may be the case that distinct repair pathways
operate on cross-links to remove the various structures formed by different cross-linking
agents. Indeed, in vitro studies have reported the involvement of different repair proteins
and pathways for different agents (26) (27).

Figure 1.1. DNA interstrand cross-linking agents covalently bound to their preferred
DNA bases. A) Nitrogen mustard (yellow) binds to guanine bases in 5’-GNC sequences.
B) Cisplatin (blue) binds to guanine bases in 5’-GC sequences. C) Mitomycin (red) C
binds to guanine bases in 5’-CG sequences. D) Psoralen (green) binds to thymine bases in
5’-TA sequences.
Another challenge to characterizing the mechanism by which cross-links are
repaired is that all cross-linking agents induce multiple forms of damage, not just crosslinks (28). This is a result of cross-linking being a multi-step reaction: the chemical agent
intercalates into DNA, covalently binds to a base, and then binds to a base on the
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opposite strand of DNA. Therefore, monoadducts are produced as precursors to crosslinks but can persist as single-stranded damage when sequence context or structural
properties preclude the second binding reaction (29, 30). Since cells treated with crosslinking agents present a variety of monoadducts, cross-links, and potentially other forms
of DNA damage, it is challenging to design experiments where the defect or phenotype
can be specifically attributed to the presence or repair of the cross-link. One approach
previously used to address this challenge has been to create site-specific cross-links in
plasmids and study repair with purified repair proteins or extracts in vitro (31). While this
method has provided insight in identifying gene products that are capable of binding to or
incising cross-links, it largely remains unknown if these gene products operate on crosslinks similarly in vivo or contribute to the repair process of a living organism.
Since there are no agents that exclusively produce cross-links, a second approach
to identifying cross-link-specific effects has been to compare monofunctional agents to
related cross-linking agents (32–35). Psoralen has a variety of isomers that have been
shown to vary in photo-reactivity with DNA. For example, Angelicin is a psoralen
derivative that, due to its angular structure, only produces monoadducts with native DNA
(36, 37). This isomer binds to the 5,6-double bond of thymine bases with the 3,4-double
bond of its pyrone ring by way of UVA photoreaction (38) (Figure 1.2A). 8methoxypsoralen is another isomer of psoralen that is often used as the cross-linking
agent alongside angelicin, since it produces a higher ratio of cross-links to monoadducts
than that of psoralen (39). Like psoralen, the linear structure of this molecule allows for
binding at the 4’,5’- and 3,4- positions of its furan and pyrone rings, respectively, to the
5,6-double bonds of adjacent thymine bases (40, 41). There are four major products that
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result from 8-methoxypsoralen plus UVA light and native DNA: two diasterometric
furan-side monoadducts, one pyrone-side monoadduct, and one interstrand cross-link
where the furan-side monoaddition necessarily precedes the pyrone-side addition (29, 42)
(Figure 1.2B-E).

Figure 1.2. Angelicin and 8-methoxypsoralen are furocoumarin isomers that intercalate
in DNA and preferentially bind to thymine bases in photocycloaddition reactions. 8methoxypsoralen differs from angelicin in that it is linear in structure and has a methoxy
group at the 8-position. A) Angelicin pyrone-side monoadduct. Angelicin reacts with a
single UVA photon to form a pyrone-side cyclobutane ring (blue) with thymine. B) 8methoxypsoralen furan-side monoadduct. 8-methoxypsoralen reacts with a single UVA
photon to form a furan-side cyclobutane ring (orange) with thymine. C) 8methoxypsoralen furan-side monoadduct (diastereomer of B). D) 8-methoxypsoralen
pyrone-side monoadduct. 8-methoxypsoralen reacts with a single UVA photon to form a
pyrone-side cyclobutane ring with thymine. E) 8-methoxypsoralen interstrand cross-link.
Structure C is the only monoadduct product that can result in DNA interstrand cross-link
product when reacted with an additional UVA photon and adjacent thymine base.
To effectively compare the effects and cellular responses of monofunctional
psoralens with bifunctional psoralens it is important to standardize the doses to ensure
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that comparable levels of damage are formed in each case. Using radioactively labeled
psoralen and angelicin to quantify the respective levels of photoreaction of E. coli DNA,
Borden et al. demonstrated that psorlen molecules photoreact with DNA about five times
as frequently as angelicin molecules when drugs are used at equal concentration and cells
are UVA-irradiated for 4-16 minutes (33). Additionally, some bifunctional psoralen
isomers, such as 8-methoxypsoralen and amotosalen, produce different ratios of crosslinks and monoadducts in cells and this should be considered when comparing damage to
angelicin-treated cells (43).

DNA interstrand cross-link repair models
DNA damage occurs frequently in cells and is caused by both endogenous and
exogenous agents. In most cases, damage is confined to a single strand or base of DNA
and can be repaired faithfully by enzymes that utilize the undamaged complementary
strand as a template for resynthesis following incision of the damaged strand (44).
However, DNA interstrand cross-links covalently link complementary strands and
complicate, in theory, how cells could accurately repair this form of damage. A number
of models have been proposed throughout the course of cross-link repair studies that each
suggest the involvement of multiple repair pathways.
In early experiments in E. coli, the removal of bi-functional alkylation agents
from DNA was detected by examining the alkylation products in E. coli DNA following
treatment with 35S-labeled mustard gas via chromatographic analysis and suggested a
possible cellular repair capacity for interstrand cross-links (45–47). Additionally, these
studies demonstrated that a mutant strain incapable of removing thymine dimers from
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DNA was likewise incapable of removing mustard gas lesions. In mammalian L-cells,
Reid and Walker (48) also demonstrated via chromatographic analysis that excision of
cross-linked DNA occurred and proposed a two-step process of unhooking the damage to
remove the product.
As a follow up to these studies, Cole (49) was able to show in alkaline sucrose
sedimentation profiles that the DNA from E. coli cells treated with a psoralen derivative
and UVA light was cut into discrete pieces following incubation periods and that mutant
recA- cells did not exhibit the same joining products. This evidence, coupled with
alkaline CsCl density profiles that showed fragmented DNA was joined with DNA
strands of higher molecular weight in recA+ cells treated with psoralen and UVA but not
recA- cells, was interpreted to suggest that recombination events were involved in crosslink repair. Thus one of the early models for repair proposed that incisions surrounding
the cross-link on one strand of DNA by the nucleotide excision repair pathway are
followed by a recombinational reaction that utilizes a homologous template to accurately
resynthesize over the partially incised cross-link (49). Van Houten et al. later
demonstrated in vitro that incubating a site-specific psoralen cross-link with purified
UvrABC excision nucleases produces dual incisions on a single strand of DNA
surrounding the cross-link (50). The UvrABC excinuclease complex operates in the
nuclease excision repair pathway in prokaryotes and is associated with the removal of a
diverse range of base damage and monoadducts (51, 52). The results from studies by
Cole and Van Houten taken together strongly supported the idea that nucleotide excision
repair promoted the primary incision step of cross-link removal and this model remains
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prominent in the literature today. Be that as it may, the sequential repair events are still
unclear.
In theory, after the initial incision event a cross-link would remain bound to the
unincised DNA strand and prevent displacement of the damaged strand by helicases, such
as UvrD. Similarly, a second round of excision repair operating directly on the incised
region would lead to a double-strand break and result in a deletion of the sequences in the
direct vicinity of the lesion. Thus, repair models invoked the idea that recombination may
operate to recruit and provide an undamaged substrate that could be used as a template
for the repair of this region. To examine how such a hypothetical substrate may be
processed, Cheng et al. (53) used a biochemical approach involving a psoralenmonoadducted oligomer that was incubated with RecA, paired with a homologous region
in a plasmid, and then UVA irradiated to form a three-stranded complex with a sitespecific cross-link. This complex was incubated with dNTPs, radioactively labeled
dCTPs, and proteins involved in the nucleotide exicison repair pathway—UvrA, UvrB,
UvrC, helicase II, DNA polymerase I, and DNA ligase—and then samples were restricted
and electrophoresed on native acrylamide gel to show that the three-stranded complex
was a viable substrate following the initial incision repair process. These experiments
contributed to the development of a cross-link repair model that includes nucleotide
excision repair pathway coupled with recombination (Figure 1.3A). Interestingly, the
helicase II—UvrD in E. coli—has yet to be analyzed for its involvement in cross-link
repair in vivo. The significant role UvrD plays in the turnover of UvrABC exinuclease
complex during the repair of UV damage (54) makes the uvrD gene product an
interesting candidate for repair role of interstand cross-link damage.
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An issue raised by critics of the initial model pointed out that should the crosslink form in a region of the chromosome that has not yet been replicated no substrates for
recombination would be available and faithful repair would not be possible. To address
this, an alternative repair model was proposed and suggested that after initial incisions by
the ABC excinuclease complex specialized translesion polymerases could replicate
across the incised oligo-lesion product and provide a template for the second round of
incisions (Figure 1.3B) (55). This idea was initially supported by a report that plasmids
containing an interstrand cross-link displayed reduced survival when transformed into a
polB- (polymerase II) mutant (56). Survival experiments in yeast cells demonstrated that
rev3 mutants were sensitive to mitomycin C cross-links in stationary but not exponential
phase (57), supporting the idea that an alternative repair pathway is involved when
recombination products are not available as chromosome templates. Additionally, Zheng
et al. observed mammalian cells that were defective in nucleotide excision repair and
lesion bypass by PolH exhibited reduced repair of a site-specific mitomycin C cross-link
in a reporter gene of a plasmid but that repair was complemented when transfected with a
PolH expression vector (58). However, the potential role for translesion synthesis during
cross-link repair in vivo has not been systematically examine in bacteria.
Beyond the initial incisions of interstrand cross-links by the UvrABC
excinuclease complex alternative models for repair completion have proposed that the
process advances through a double-strand break intermediate (Figure 1.3C) (59–63).
While exploring this possibility, Kitayama et al. demonstrated by sedimentation profiles
on neutral sucrose gradients that D. radiodurans treated with mitomycin C exhibited
double-strand break structures in DNA (64). Additional support for this intermediate
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comes from mammalian studies, one of which detected the presence of double-strand
breaks in DNA by running V79 cells treated with nitrogen mustard in plugs by pulse field
gel electrophoresis (60). A potential role for double-strand break repair in the survival of
cross-links has not been examined in E. coli.
In more recent studies with mammalian cells a number of base excision repair
proteins have been shown to bind or incise interstrand cross-links (Figure 1.3D) and
affect survival, although reports differ as to interpretation of the effects. An initial report
found that in vitro, Endo VIII-like protein (NEIL1) could initiate repair on psoraleninduced monoadducts or cross-links in DNA substrates mimicking those encountered
during the second round of incisions (65). However, others have reported that NEIL1
binding prevents the normal mechanism of incision and renders cells more resistant to
interstrand cross-links when mutated (35, 66). Similarly, APE1—the primary AP
endonuclease in mammalian cells—has been reported to impede the normal processing of
cisplatin-induced cross-links, and could lead to cisplatin resistance when mutated (27,
67). Finally, recent biochemical studies have suggested that NEIL3 promotes incision at
psoralen interstrand cross-links and therefore promotes repair (26). However whether this
occurs in vivo or affects cell survival was not determined.
Because most of these models lack in vivo evidence or characterization in
bacterial cells, I have chosen to examine mutants from repair pathways previously
implicated in order to determine which gene products are specifically involved in
processing cross-links. In Chapter II I describe experiments using mutants from
nucleotide excision repair, translesion synthesis, and double-strand break repair pathways
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and Chapter III I discuss the possible involvement of base excision repair proteins. All
results are summarized and conclusions are discussed in Chapter IV.

Figure 1.3. Prominent models for repair of DNA interstrand cross-links. A) Nucleotide
excision repair and homologous recombination. The interstrand cross-link (i) is initially
incised by the nucleotide excision repair complex (ii) before the gap on the incised strand
is filled in by recombination using a sister chromosome (iii). Nucleotide excision repair
could then, in theory, make a second round of incisions on the opposing strand (iv),
which would be filled in using the ‘newly formed’ complementary strand as a template
(v) (adapted from (38, 49, 68)). B) Nucleotide excision repair and translesion synthesis.
The interstrand cross-link (i) is initially incised by the nucleotide excision repair complex
(ii) before translesion synthesis filled in the gap (iii). Nucleotide excision repair then
makes a second round of incisions to remove the lesion (iv) before the remaining gap is
resynthesized using the ‘newly formed’ complementary strand as a template (v) (adapted
from (55)). C) Excision-mediated double-strand break repair. Following an encounter
with the replication fork (i), incision of the interstrand cross-link by nucleotide excision
repair results in a double-strand break (ii). Translesion polymerases restore the incised
template (iii) before a second round of nucleotide excision repair removes the cross-link
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and restores the template (iv). Recombination then repairs the double-strand break to
restore the replication fork (v) (adapted from (60–62)). D) Base excision repair. Two
replication forks converge on a cross-link (i) and a glycosylase creates an abasic site on
one side of the damage (ii). Translesion polymerases synthesize over the abasic site (iii)
as well as the unhooked cross-link (iv) and then the remaining single-stranded damage on
the parent template is removed and resynthesized (v) (adapted from (26)).
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Chapter II. Limited capacity or involvement of excision repair, double-strand breaks, or
translesion synthesis for psoralen cross-link repair in Escherichia coli

Abstract
DNA interstrand cross-links are complex lesions that covalently bind complementary
strands of DNA and whose mechanism of repair remains poorly understood. In
Escherichia coli, several gene products have been proposed to be involved in cross-link
repair based on the hypersensitivity of mutants to cross-linking agents. However, crosslinking agents induce several forms of DNA damage, making it challenging to attribute
mutant hypersensitivity specifically to interstrand cross-link damage. To address this, we
compared the survival of UVA-irradiated mutants in the presence of 8methoxypsoralen—which forms interstrand cross-links and monoadducts—to that of
angelicin—a congener forming only monoadducts. We show that incision by nucleotide
excision repair is not required for resistance to interstrand cross-links. In addition, neither
RecN nor DNA Polymerases II, IV, or V is required for interstrand cross-link survival,
argument against models proposing that double-strand break intermediates or translesion
polymerases participate in the repair process. Finally, estimates based on Southern
analysis of DNA fragments in alkali agarose gels indicate that lethality occurs in wild
type cells at doses producing as few as one interstrand cross-links per genome. These
observations suggest that E. coli lacks an efficient repair mechanism for this form of
damage.

Introduction
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DNA interstrand cross-links are highly cytotoxic lesions induced by a variety of
bifunctional agents, including nitrogen mustard, cisplatin, mitomycin C, and psoralen
plus UVA light (1–5). Cytotoxicity is thought to result from the covalent linkage between
both DNA strands preventing strand separation and thus inhibiting essential processes
like replication or transcription at these sites (2, 6). Cross-linking agents are widely used
as chemotherapeutics and have been effectively employed in the treatment of a range of
hyperplastic or dysplastic conditions such as psoriasis or white leprosy, respectively (7–
10). Their effectiveness in treating these disease states has led to an interest in
understanding how these medically relevant lesions are processed by cells with the goal
of developing novel targets or strategies for chemotherapeutics.
Although several genes have been isolated that, when mutated, render cells
hypersensitive to cross-linking agents (11–13), many aspects of how these complex
lesions are repaired and processed in cells remain unknown. Additionally, all crosslinking agents induce multiple forms of DNA damage, making it difficult to attribute
mutant hypersensitivity specifically to defective repair of the cross-link lesion (5, 14–17).
Various models for interstrand cross-link repair have been proposed, each involving
multiple repair pathways that couple components of nucleotide excision repair with
recombination, translesion synthesis, or alternative nuclease complexes (18–21).
However, after the initial incision event, all of these models remain highly speculative
and are hampered by the challenges of reconstituting this multi-step, multi-pathway
repair process.
Based on early experiments in E. coli, researchers recognized the challenge of
repairing a DNA interstrand cross-link due to the covalent attachment of this adduct to
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both DNA strands. Researchers inferred that repair would likely require the sequential
action of multiple pathways (12, 22, 23). The hypersensitivity of nucleotide excision
repair and recombination mutants, uvrA and recA, respectively, suggested that nucleotide
excision repair may initiate incisions on one strand and that recombination from a sister
chromosome would then provide an undamaged template to replace the incised region. A
second round of incisions by nucleotide excision repair could then complete the repair
process. In support of this model, biochemical studies found that the UvrABC nucleotide
excision repair complex would recognize and incise one strand of a cross-link in vitro
(18). Other studies demonstrated that RecA could promote strand exchange at this site in
vitro if the gapped region were first expanded through exonucleolytic degradation (24).
Although the mechanisms suggested by this model could in principle repair a cross-link,
it should be noted that uvrA and recA mutants are hypersensitive to almost all forms of
DNA damage, not just cross-links. And currently, no intermediates for the events
following the initial incision have been characterized or observed in vivo.
A feature common to most models to DNA interstrand cross-link repair is that the
process is initiated by the nucleotide excision repair pathway—the primary pathway by
which a diverse range of base damage and monoadducts are repaired (25, 26). In E. coli,
UvrA, UvrB, and UvrC form an excinuclease that makes dual incisions surrounding a
DNA lesion on the damage-containing strand (27). Cells deficient in any one of these
gene products fail to make incisions and exhibit elevated levels of recombination,
genomic rearrangements, and cell lethality (28–31). UvrD is a helicase that promotes
removal of the incised oligo and releases the exinuclease complex from DNA before
DNA polymerase I fills in the gap and DNA ligase seals the nick to complete repair (32–
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34). In the absence of UvrD the excinuclease complex remains bound to the initial adduct
and cells are almost as hypersensitive and defective at removing lesions from the genome
as those lacking UvrA, UvrB, or UvrC (35)(36).
Several in vitro studies suggest that nucleotide excision repair proteins act to
initiate the processing of interstrand cross-links and in vivo studies have shown that uvrA,
uvrB, and, uvrC mutants are hypersensitive to DNA interstrand cross-linking agents and
fail to incise cross-links (18, 23, 24, 37–41). Cho, an alternative nuclease with homology
to UvrC has also recently been shown to contribute to survival in the presence of 8methoxypsoralen, perhaps by enhancing the rate of the initial incision (41, 42). However,
the role of UvrD in interstrand cross-link repair has not yet been examined in vivo. It has
been postulated that UvrD may displace a cross-linked structure following the initial
incision event by UvrABC complex so that the gap could be filled in by a translesion
polymerase (18, 43). What complicates this is that UvrD is required for exinuclease
turnover at monoadducts and turnover may still be required to allow further cross-link
repair events to occur (34). It is possible that UvrD may also be required for strand
displacement following the second round of incisions of an unhooked cross-link.
Other models noted that DNA cross-links occurring in nonreplicating cells or in
unreplicated regions of the genome would not have a sister chromosome available for
recombination (19, 44). To account for this, it was proposed that alternative DNA
polymerases might replicate across the incised oligo-lesion product to provide a template
for the second round of incisions. Support for this idea came from early reports that
plasmids containing an interstrand cross-link displayed reduced survival when
transformed into a pol B (Polymerase II) mutant (44). However, several labs have since
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been unable to verify a range of phenotypes reported for this polB strain (44–46),
implying the effect may have been to secondary mutation within this particular strain
(47–49). A later biochemical study also showed that PolV, the dinB gene product, could
synthesize through templates containing an unhooked oligo-bound cross-link in vitro,
supporting the possibility that translesion synthesis could carry out this hypothetical step
in cells (49). However, to date the potential role for translesion synthesis during crosslink repair in vivo has not been systematically examined in bacteria.
A third model for the repair of cross-links comes from studies in mammalian cells
and suggests that repair is coupled to replication and proceeds through a double-strand
break intermediate (50–52). In this model, interstrand cross-links that block replication
forks are incised by the Fanconi anemia pathway/nucleotide excision repair proteins
(ERCC1/XPF endonuclease) as well as other structure-specific nucleases and result in
double-strand break intermediates. Consistent with this, double-strand breaks are detected
in both yeast and mammalian cells following treatment with interstrand cross-linking
agents and double-strand repair mutants are hypersensitive to these drugs (50–52).
Similarly, the bacterial UvrABC excinuclease has been shown capable of incising both
strands of an interstrand cross-link in vitro (53, 54). However, whether double-strand
breaks arise in vivo during the bacterial repair process has not been directly examined.
To further characterize the pathways and gene products involved in the repair of
DNA interstrand cross-links, we compared the survival of E. coli cultures irradiated with
UVA in the presence of 8-methoxypsoralen or angelicin. The comparison between these
two isomers allows us to differentiate between genes products that are involved in the
general repair of monoadducts from those that have a specific or concurrent role in cross-
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link repair (55). 8-methoxypsoralen is a linear molecule capable of forming DNA
monoadducts and interstrand cross-links whereas angelicin has an angular structure that
only allows it to produce monoadducts (4, 41, 56, 57). Using this approach, mutants
lacking gene products that specifically contribute to the repair of interstrand cross-links
would be expected to exhibit greater sensitivity to 8-methoxypsoralen-induced damage
relative to angelicin-induced damage when compared to the sensitivity of wild type
cultures (55). Here, we examined several candidate mutants from pathways that have
been proposed to be involved in the repair of cross-links based on current models in
bacteria or mammals.

Methods
Bacterial Strains. The parent strain used in this study is SR108, a thyA36 deoC2
derivative of W3110 (58). Isogenic strains lacking uvrA (HL952), uvrD (CL1302), polB
dinB umuDC (CL646) were constructed using standard P1 transduction methods that
have been described previously (48, 59). CL912 (DY329 recN::cat) was constructed
using the recombineering strain DY329 (60). The chloramphenicol resistance gene was
amplified from TP507 (61) using PCR primers recNF-catF
5’GTAATGGTTTTTCATACAGGAAAACGACTATGTTGGCACAATGAGACGTTG
ATCGGCAC, and recNR-catR
5'GCAGGAAAAAAGTTTACGCTGCAAGCAGTTCTTTCGCATTCTTTCGAATTTC
TGCCATT. PCR product was then transformed into DY329 to generate CL912, selecting
for chloramphenicol resistance. The gene replacement was transferred into SR108 using
standard P1 transduction to generate CL915 (SR108 recN::cat).
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Psoralen-UVA and Angelcin-UVA Survival Assays. Fresh overnight cultures were diluted
1:100 in Davis medium (62) supplemented with 0.4% glucose, 0.2% Casamino Acids,
and 10 µg/mL thymine (DGCthy) and grown at 37°C to an optical density of 0.4 at
500nm (OD600). At this time, 10 µg/mL of 8-methoxypsoralen (Acros Organics, item
298-81-7) or 40 µg/mL of angelicin (Sigma-Aldrich, item A0956) was added to the
cultures and incubation continued for 10 min. Cells were then irradiated using two 32watt UVA bulbs (Sylvania) with a peak emittance of 320 nm at an incident dose of 6.3
J/m2/s. Angelicin-treated cells were UVA-irradiated for longer time increments than 8methoxypsoralen-treated cells in order to achieve comparable kill curves for wild type
cells in either condition. At the times indicated, 100-µL aliquots were removed from each
culture and serially diluted in 10-fold increments. Triplicate 10-µL aliquots of each
dilution were spotted on Luria-Bertani agar plates supplemented with 10 µg/mL thymine
(LBthy) and incubated at 37°C. Viable colonies were counted the next day to determine
the surviving fraction. The lethal dose in 8-methoxypsoralen-treated cultures was
determined based on the Poisson expression, P(i) = xie-x/i!, as the fraction of surviving
cells (those have zero lethal lesions) at a dose where cells in the population have an
average of 1 lethal lesion; i = 0, x = 1.

In vivo detection of DNA interstrand cross-links. Cultures containing the plasmid
pBR322 were grown overnight at 37°C in DGCthy medium supplemented with 50 µg/mL
of ampicillin. A 0.1-mL aliquot from this culture was pelleted and resuspended in 10-mL
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DGCthy medium without ampicillin and grown in a 37°C shaking water bath until grown
to an OD600 of 0.4.
Cultures used for the incision/recovery assay were exposed to 20 µg/mL 8methoxypsoralen for 10 min at 37°C and subsequently irradiated with a UVA dose of 5.7
kJ/m2. Irradiated cultures were then incubated for a recovery period of 120 min where
0.75-mL aliquots were collected at times indicated and then transferred to an equal
volume of ice-cold 4X NET buffer (10mM Tris [pH 8.0], 40mM EDTA, 400mM NaCl).
Cultures used for the dose-dependent induction of cross-links were exposed to 10
µg/mL of 8-methoxypsoralen for 10 min at 37°C and UVA irradiated. Aliquots of 0.75mL were collected during the course of the UVA treatment at the doses indicated and
transferred to an equal volume of ice-cold 4X NET buffer.
Cells were pelleted, resuspended in 130-µL lysis buffer (1 mg/mL lysozyme, 0.5
mg/mL RNaseA in 10 mM Tris, 1 mM EDTA [pH 8.0]), and incubated at 37°C for 30
min. Then, 10-µL of 10 mg/mL proteinase K and 10-µL of 20% Sarkosyl were added to
the samples and incubation continued for 1 hour at 37°C. Samples were extracted with
four volumes of phenol-chloroform, followed by two volumes of chloroform and then
dialyzed against 200-mL of 1 mM Tris (pH 8.0) and 1 mM EDTA for 45 min using 47mm Millipore 0.025-µM pore disks. The DNA was digested with HindIII (Thermo
Fisher) overnight at 37°C. Samples were electrophoresed on a 0.75% alkaline agarose gel
in 30 mM NaOH, 1 mM EDTA at 1 V/cm for 16 hours. DNA in the gels was then
transferred to Hybond N+ nylon membranes (GE Healthcare) using standard Southern
blotting techniques. The plasmid DNA was detected by probing with 32P-labeled pBR322
that was prepared by nick translation (Roche) using alpha 32P-dCTP > 6000Ci/mmol
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(Perkin-Elmer). Southern blots were visualized using a Storm 840 phosphorimager (GE
Biosciences) and its associated ImageQuant analysis software.
The fraction of 8-methoxypsoralen cross-links formed at each time point was
calculated as the ratio of DNA band running at about twice the molecular weight of the
linear band to the total DNA per lane and normalized to the fraction of cross-links in
untreated samples.
Fraction of cross-linked plasmid = (XDtime(x)/TDtime(x)) – (XDuntreated/TDuntreated),
where XD represents cross-linked DNA and TD represents total DNA.
The best-fit line for the fraction of lesion-free plasmid was calculated from the
Poisson distribution based on the assumption that two photons must be absorbed to form
a cross-link (40) (23) (63), where y = P(0) + P(1) = e-(m)x + (m)xe-(m)x.

Results
uvrD mutants are hypersensitive to monoadducts but are almost as resistant as wild
type cells when both monoadducts and cross-links are present
To investigate the role of nucleotide excision repair enzyme UvrD in the
processing of cross-links, we examined the survival of uvrD mutants following UVA
irradiation in the presence of either 8-methoxypsoralen or angelicin. A previous study by
Bordin et al. has shown that psoralen and angelicin photoreact with DNA in E. coli at a
ratio of about 5:1 when irradiated with equal drug concentrations and doses of UVA light
(56) whereas 8-methoxypsoralen forms adducts in native DNA at a ratio of about 4:1
compared to angelicin (64). Therefore we chose to treat cells with 10 µg/mL 8methoxypsoralen or 40 µg/mL angelicin in order to induce a comparable number of
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lesions in either treatment. Under these conditions, the survival of wild type cultures in
the presence of angelicin was reduced by more than two orders of magnitude within 12
kJ/m2 of UVA irradiation (Figure 2.1A). Alternatively, a loss of viability of the same
magnitude was observed within 3 kJ/m2 in wild type cells treated with 8methoxypsroalen, consistent with the high lethality associated with the formation of DNA
interstrand cross-links (Figure 2.1B). By comparison, uvrA mutants were hypersensitive
to both angelicin and 8-methoxysproalen, with survival decreasing greater than two
orders of magnitude after 1 kJ/m2 UVA irradiation in each case.
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Figure 2.1. UvrD contributes to survival in the presence of monoadducts but not DNA
interstrand cross-links. The survival of WT (Filled squares), uvrA (filled circles), and
uvrD (open circles) mutants following UVA irradiation in the presence of A) 40 µg/mL
angelicin or B) 10 µg/mL 8-methoxypsoralen is plotted. Plots represent the average of at
least 4 experiments. Error bars represent standard error of the mean.
When we examined uvrD cultures under the same conditions, we observed that
these mutants were nearly as hypersensitive to angelicin-induced monoadducts as uvrA
mutants (Figure 2.1A), consistent with what has been observed for other forms of base
damage and monoadducts such as pyrimidine dimers and N-acetoxy-N2acetylaminofluorene (65–67). However, uvrD mutants treated with 8-methoxypsoralen
required over 2 kJ/m2 UVA irradiation to reduce survival by two orders of magnitude. At
this dose, uvrD mutants exhibit a nearly wild type-like resistance. Two inferences can be
made from this observation: First, the comparable resistance of wild type and uvrD
mutants implies that UvrD does not contribute to interstrand cross-link repair. If the
nucleotide excision repair complex initiates incisions at cross-links, one can infer that
UvrD is not required for either oligo removal or excinuclease turnover during the first
incision, nor would it be required if a second round of incisions occurs as postulated in
many models such as those shown in Figure 1. Second, it is notable that uvrD mutants are
hypersensitive in the presence of monoadducts (Figure 2.1A), but as resistant as wild type
cells when both monoadducts and interstrand cross-links are present. This allows us to
infer that the lethality observed in wild type cells is caused almost exclusively by the
presence of DNA interstrand cross-links. Thus, although 8-methoxypsoralen
monoadducts are formed at higher frequencies than interstrand cross-links, wild type
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cultures are able to efficiently repair and survive in the presence of the former lesion and
lethality results from the presence of interstrand cross-links.
The nearly normal resistance of uvrD mutants to interstrand cross-links might
suggest that incision occurs normally in these mutants. To examine this as a possibility,
we compared the rate that interstrand cross-links were incised in wild type cells
compared to uvrA and uvrD mutants. To this end, cultures containing pBR322 were
treated with 8-methoxypsoralen and UVA light and then allowed to recover. At various
times during the recovery period, total genomic and plasmid DNA was purified from
aliquots of the cultures. The purified DNA was the restricted with HindIII to linearize the
plasmid and examined by Southern analysis following alkali denaturing agarose gel
electrophoresis to determine the rate that DNA interstrand cross-links were incised over
time (Figure 2.2A). In wild type cultures immediately following 5.7 kJ/m2 of UVA
irradiation, 3.6% of the plasmids contained a DNA interstrand cross-link. The fraction of
DNA migrating in the cross-link region of the gel decreased over the recovery period,
with more that three quarters of the cross-links being incised by the end of the 120minute time course (Figure 2.2B). In uvrA mutants, 7.9% of the molecules initially
contained cross-links following UVA irradiation at the same dose. In these cultures,
incisions of cross-links were severely impaired, as most cross-links persisted in the DNA
throughout the 120-minute recovery period, consistent with previous studies showing
defective incisions in these mutants. Surprisingly, although uvrD cultures are almost as
resistant to cross-links as wild type cultures, the mutants were impaired in their ability to
make incisions, similar to uvrA mutants. This observation implies that although
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nucleotide excision repair proteins may be involved in the removal of cross-links, these
incisions are not necessarily productive.

Figure 2.2. uvrD mutants have diminished capacity for incising DNA interstrand crosslinks. A) Cultures containing the plasmid pBR322 were UVA-irradiated with 5.7 kJ/m2 in
the presence of 20 µg/mL 8-methoxypsoralen and then allowed to recovery for 120minutes. To observe the cross-links remaining in the DNA at each time-point, total
genomic and plasmid DNA was purified from cells, restricted with HindIII to linearize
the plasmid, and examined by Southern analysis following alkali gel electrophoresis
using 32P-labeled pBR322 as probe. B) The fraction of cross-links remaining in the DNA
over the recovery period is plotted for WT (filled squares), uvrA (filled circles), and uvrD
(open circles). The initial percentage of cross-linked plasmids immediately following
UVA irradiation were as follows: WT, 3.6 ± 1.0%; uvrA, 7.9 ± 2.3%; and uvrD 6.6 ±
0.7%. Plots represent the average of 7 experiments for WT and 4 experiments for uvrA
and uvrD mutants. Error bars represent standard error of the mean.
Translesion DNA polymerases do not contribute to survival in the presence of
interstrand cross-links
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Following the initial incisions by nucleotide excision repair, models in both
bacteria and mammals have proposed that translesion synthesis by alternative
polymerases function to replicate across an incised oligo-cross-link intermediate to
provide a template for the second round of incisions (20, 68, 69). Biochemically, Pol
IV—the dinB gene product—is capable of synthesizing through templates containing an
unhooked oligo-bound cross-link in vitro, supporting the possibility that translesion
synthesis could carry out this hypothetical step (49). In mammals, several polymerases
have been speculated to participate in cross-link repair based on mutant hypersensitivity
to chemicals that form cross-links in addition to in vitro evidence for the ability of certain
polymerases to synthesize past partially incised cross-links (69–73). However, the
potential role for translesion polymerases during cross-link repair in vivo has not been
examined in bacteria. To this end, the comparative survival of a mutant lacking all three
translesion polymerases—Pol II, Pol IV, and Pol V—was examined following UVA
irradiation the presence of angelicin or 8-methoxypsoralen. Relative to wild type cells,
the absence of translesion polymerases rendered cells modestly sensitive to monoadducts
formed by angelicin (Figure 2.3A). Comparatively, in the presence of both monoadducts
and DNA interstrand cross-links, the sensitivity remained nearly identical (Figure 2.3B).
The observation that the presence of DNA interstrand cross-links does not further
sensitize the polymerase mutants beyond that seen in the presence of monoadducts alone
implies that the translesion polymerases are not contributing to the survival of interstrand
cross-links in vivo.
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Figure 2.3. The transleison DNA polymerases do not contribute to survival in the
presence of 8-methoxypsoralen-induced DNA interstrand cross-links. The survival of WT
(filled squares), uvrA (filled circles), and polB dinB umuDC (open diamonds) mutants
following UVA irradiation in the presence of A) 40 µg/mL angelicin or B) 10 µg/mL 8methoxypsoralen is plotted. Plots represent the average of at least 3 experiments. Error
bars represent standard error of the mean. WT and uvrA from Figure 2.1 shown for
comparison.
Double-strand breaks are not a prominent intermediate in the repair of DNA
interstrand cross-links
Several models for interstrand cross-link repair propose that repair proceeds
through a double-strand break intermediate and requires recombination for repair to occur
(50, 52–54, 74–78). Several genes in E. coli, when mutated, render cells hypersensitive to
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double-strand breaks. However, most of these mutants, including recA, are hypersensitive
to multiple forms of DNA damage. recN-mutants are unique in that they are
hypersensitive to agents that generate double-strand breaks such as gamma irradiation,
mitomycin C, nalidixic acid, or enzymatic restriction but are resistant to other forms of
DNA damage that only induce single-strand lesions or monoadducts such as UV (79).
Consistent with this role in repairing double-strand breaks, purified RecN binds and
protects double-strand DNA ends and interacts with RecA to stimulate its ATPase
activity and facilitate its loading at these damaged sites (80–82). If double-strand break
intermediates form during the processing of interstrand-cross links, then one would
expect recN mutants to be sensitive to 8-methoxypsoralen but not to angelicin. To
examine this directly, we compared the survival of recN mutants after UVA irradiation in
the presence of angelicin and 8-methoxypsoralen. As shown in Figure 2.4A, recN
mutants were modestly sensitive to monoadducts formed in the presence of angelicin and
UVA light when compared to wild type cultures. Cells lacking RecN were also modestly
sensitive to 8-methoxyporalen treatment, however the degree of sensitivity of this strain
relative to wild type cells was similar irrespective of the chemical agent used (Figure
2.4B). The similar sensitivity of recN mutants and wild type cells in the presence of
monoadducts alone or both monoadducts and cross-links suggests that recN is not
contributing to survival in the presence of interstrand cross-links. By comparison, recA
mutants were hypersensitive to treatments that produced cross-links and monoadducts as
well as monoadducts alone (Figure 2.4).
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Figure 2.4 RecN, which is required for resistance to double-strand breaks, does not
contribute to survival in the presence of DNA interstrand cross-links. The survival of WT
(filled squares), recA (filled triangles), and recN (open triangles) mutants following UVA
irradiation in the presence of A) 40 µg/mL angelicin or B) 10 µg/mL 8-methoxypsoralen
is plotted. Plots represent the average of at least 3 experiments. Error bars represent
standard error of the mean. WT from Figure 2.1 shown for comparison.
Repair of interstrand cross-links is inefficient in E. coli
The data presented in Figures 2.1-2.4 suggest that incisions by nucleotide excision
repair, processing by double-strand break repair, or synthesis by translesion polymerases
does not necessarily contribute to the survival of E. coli in the presence of interstrand
cross-links. The survival results coupled with what we observed in the cross-link incision
rate assay, prompted us to quantify the number of cross-links formed in vivo under the
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conditions used in our survival analysis. To accomplish this, we examined cross-link
formation as a function of UVA dose on pBR322, an endogenous plasmid in uvrAdeficient cultures. Since uvrA mutants fail to incise cross-links efficiently (Figure 2.2),
these lesions accumulate and persist on the plasmid and therefore can be directly
quantified. To this end, cultures containing plasmid pBR322 were grown in media
containing 10 µg/mL 8-methoxypsoralen and irradiated with increasing UVA doses.
Total genomic and plasmid DNA was then purified and digested with HindIII to linearize
the plasmid. The samples were electrophoresed in an alkaline denaturing agarose gel and
Southern analysis was used to identify and quantify the cross-links formed at each UVA
dose (41, 83). As shown in Figure 2.5A, cross-linked structures appear as the higher
migrating species in the Southern blot relative to the single-stranded linear DNA band.
The percent of cross-linked DNA at each UVA dose was calculated by dividing the area
of cross-linked plasmid DNA over total DNA per lane and then subtracting the same ratio
of the untreated lane. Then, the inverse of each data point was plotted as percent crosslink-free plasmid as a function of UVA dose (Figure 2.5B) and the best-fit line was
calculated under the assumption that DNA interstrand cross-links require absorption of
two photons and, as demonstrated by a number of studies, form with second-order
kinetics as a function of UVA dose (12, 23, 40).
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Figure 2.5. One cross-link is sufficient to inactivate our parental strain of E. coli. A)
Dose response of interstrand cross-link formation in vivo. uvrA mutants containing
plasmid pBR322 were UVA-irradiated at the indicated dose in the presence of 10 µg/mL
of 8-methoxypsoralen. DNA from cultures were the immediately purified and analyzed as
in Figure 2.2 to observe the instrand cross-links formed at each dose. B) The percent of
cross-link-free 4.3-kb plasmids remaining at each dose is plotted. The corresponding
number of cross-links this represents per 4.6-Mb genome is also shown. Plots represent
the average of 3 experiments. Error bars represent standard error of the mean. The best-fit
line was calculated from the Poisson expression based on the assumption that absorption
of 2-photon event is required to form an interstrand cross-link(40) (23) (63). The fraction
of cross-link-free plasmids decreased at a rate of where y = P(0) + P(1) = e-(m)x + (m)xe-(m)x.
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Using this technique we are reasonably able to quantify cross-links when ~1% of
the plasmids have at least one cross-link. Per the best-fit line in Figure 2.5B, this 1%
detection limit corresponds to a minimum UVA dose of ~6.5 kJ/m2. Since we knew the
size of plasmid pBR322—4,361 bp—and the percent of the plasmid population that had
at least one cross-link, we were able to measure the number of cross-links induced at each
UVA dose. We then applied this calculation to the E. coli genome— ~ 4.6 Mb—to
estimate how many cross-links we were inducing per genome. A UVA dose of 6.5 kJ/m2
corresponds to roughly 11 cross-links per/genome, however, this dose well exceeds the
lethal dose in wild type cultures. Based on our analysis of wild type cultures, ~1.8 kJ/m2
UVA irradiation was required to reduce survival to 37% (Figure 2.1B). This is the UVA
dose at which cells in the culture, on average, incur one lethal lesion. Since this dose was
below the limit of detection, we estimated the number of cross-links/genome based on an
extrapolation of our dose response curve and found that this UVA dose corresponds to ~1
cross-link in wild type cells. By this estimate, cells would lack or have an extremely
inefficient system for repairing this form of damage. In uvrA mutants, lethality occurred
at ~0.4 kJ/m2, which corresponds with approximately 0.04 cross-links per genome. This
likely argues that uvrA mutants are killed by monoadducts before a cross-link is ever
encountered in these cells. We infer from these results that E. coli may lack an effective,
error-free mechanism for repairing interstrand cross-links.

Discussion
We show that although uvrD mutants are hypersensitive to monoadducts, they are
nearly as resistant as wild type cells in the presence of cross-links. The resistance of uvrD
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mutants occurs despite their impaired ability to incise these lesions, similar to uvrA
mutants. In vitro, it is well established that proteins from the nucleotide excision repair
pathway are able to recognize and incise psoralen cross-links (18) and that mutants
lacking these enzymes fail to incise cross-links and are hypersensitive to psoralen in vivo
(18, 23, 24, 37, 38, 40, 41). This has led to the proposal in most current models that
nucleotide excision repair initiates the removal of these lesion. However, nucleotide
excision repair mutants are also hypersensitive to the presence of monoadducts. Psoralen,
as with all cross-linking agents, induces monoadducts as well as cross-links which
hampers the ability to determine whether nucleotide excision repair mutants are
specifically sensitive to cross-links. The ratio of cross-links to monoadducts at a given
UVA dose and 8-methoxypsoralen concentration varies depending on the cell line and
further complicates in vivo studies using angelicin as a comparator (84–86). In the present
study, we observed that the near wild type resistance of uvrD mutants occurs despite an
inability to make incisions, demonstrating the UvrD does not contribute to the repair
process and that incisions by nucleotide excision repair enzymes are not essential for
resistance to psoralen-induced cross-links. These results imply that the incisions by
nucleotide excision repair are not contributing to survival in the presence of interstrand
cross-links.
We also tested other aspects of cross-link repair models including the presence of
a double-strand break intermediate and the participation of translesion DNA polymerases.
In both cases, we observed that mutants impaired for double-strand break repair or
lacking the translesion DNA polymerases did not exhibit any specific hypersensitivity to
cross-links beyond that observed when exposed to monoadducts alone. Furthermore, the
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hypersensitivity of these mutants was relatively modest when either monoadducts alone
or monoadducts and cross-links were present. Taken together, this results of this
comparative analysis would argue that many of the proteins and pathways frequently
proposed to participate in the repair process including nucleotide excision repair, doublestrand break repair, or translesion synthesis do not improve cell survival in the presence
of these lesions.
The lack of contribution by these pathways led us to examine the cell’s overall
repair capacity for interstrand cross-links. Our estimates, based on the differential
mobility of cross-linked fragments in alkali agarose gels, suggests that doses which
generate only 1 cross-link per genome are sufficient to inactivate our wild type strain. If
these estimates are accurate, this would be consistent with our observations that neither
nucleotide excision repair, double-strand break repair, nor translesion synthesis
contributes to survival. Further, this would argue that E. coli lacks an efficient or
effective mechanism for repairing this form of damage.
Early studies in the repair of cross-links in E. coli began with the assumption that
an effective repair pathway is likely to exist (11, 12, 14, 22, 23, 38–40, 56, 57, 87, 88).
This assumption has persisted in more recent work, including from our lab (41). Several
of these studies have characterized the survival and recovery of cultures that were treated
with psoralen plus UVA and some reported that repair mutants, such as recA and uvrA,
were hypersensitive to psoralen and that incision intermediates appeared over time but
were only re-joined in wild type cells. Although these observations were attributed to the
formation and removal of interstrand cross-links, it seems likely that most of these
phenotypes could also be attributed to a compromised ability to process monoadducts,
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which are generated at higher frequencies and require these enzymes for repair. These
studies were generally unable to differentiate between the cellular effects cause by
monoadducts or cross-links, and this issue remains a challenge in present studies.
Angelicin and psoralen have previously been used in a comparative manner to
study interstrand cross-link repair or recovery, as we have here, but these analyses were
limited to comparing the overall toxicity and mutagenicity of monoadducts to cross-links
(14, 56, 57) (89). Interestingly, in all cases, there was consensus that lethality was almost
entirely attributed to the presence of cross-links, consistent with the general idea that the
repair capacity of these lesions is limited. In one of the few studies that measured crosslinks directly, Lin et al. observed that the surviving fraction of psoralen plus UVA treated
phage was always equivalent to the fraction of phage that remained cross-link free,
consistent with the idea that cross-links cannot successfully be repaired (23).
Finally, based on our ability to detect cross-links using alkali agarose gels and
Southern analysis, we estimated that only 1 lesion was sufficient to inactivate our wild
type cells. Our limit of detection for cross-links in our assay was ~11 cross-links per
chromosome and occurred at a dose well beyond the lethal dose for our wild type culture.
Thus, if our method of quantifying cross-links is accurate, the ability of E. coli to repair
these lesions is extremely limited. The only other estimate of cross-link repair capacity in
E. coli comes from an early study by Cole (38) who reported that the AB1157 strain was
capable of surviving treatments generating 67 cross-links. Cole stated that these estimates
were derived from the elution pattern of single- and double-strand DNA from
hydroxyapatite columns, but the data and methodology were not shown. Additionally,
Cole inferred that cross-links formed at similar rates in UVA-irradiated cells as when
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DNA was purified in solution and that cross-link formation increased linearly with UVA
dose (90) (38, 91). Neither of these assumptions turned out to be correct and both would
significantly over-estimate the number of cross-links at low UVA doses (92). Subsequent
work from the group of Howard-Flanders questioned the accuracy of the hydroxyapatite
method and used alkali sucrose gradient sedimentation to demonstrate that psoralen
cross-links form with second-order kinetics, consistent with their required absorption of
two photons (40) (23). Although the Howard-Flanders studies quantified psoraleninduced cross-links and demonstrated a single cross-link was sufficient to inactivate
phage lambda, they did not determine the lethal number of cross-links for the bacteria. A
limitation in all previous studies, as well as the study presented here, is that current
methods depend on extrapolation to determine the repair capacity of cells in culture since
lethality occurs at doses below the limit of detecting these lesions directly. While the
precise number of cross-links that can be repaired varies modestly between methods of
estimation, it is clear that the repair capacity for these lesions is very limited. The limited
capacity for wild type cells to repair and survive cross-links suggests 8-methoxysporalen
plus UVA may be more comparable to treatments such as nalidixic acid or rifampicin.
Unlike irradiation with UVC, when these drugs effectively target their respective
essential cellular functions, cells lack true repair pathways for clearing this form of
damage. Earlier work noted that while highly lethal overall, cells surviving cross-links
contain high frequencies of deletions and point mutations that only appeared in
nucleotide excision-proficient strains (40) (93), consistent with the idea that a significant
portion of these repair attempts are not accurate. In mammalian cells, double-strand
breaks are proposed to form predominantly following treatment with cross-linking agents
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(75) (77) (78). It may be the case that the presence of double-strand end-joining activity
and large proportion of noncoding DNA allow mammalian cells to survive inaccurate or
deletion-prone repair events better than E. coli. This will be an addressable and important
question to focus on in our future work.
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Chapter III. Nth and Fpg Glycosylases, Xth and Nfo AP-Endonucleases sensitize
Escherichia coli to psoralen-induced DNA damage

Abstract
In mammals, there are differing reports as to how base excision repair effects the removal
and survival of cells in the presence of psoralen DNA interstrand cross-links. Bacterial
base excision repair proteins are highly conserved with their eukaryotic counterparts,
however, the functional role of base excision repair during cross-link repair in bacteria
has not been thoroughly examined. To further characterize how this repair pathway
contributes to interstrand cross-links repair, we compared the survival of UVA-irradiated
mutants in the presence of 8-methoxypsoralen—which forms interstrand cross-links and
monoadducts—to that of angelicin—a congener forming only monoadducts. We show
that inactivating either Fapy or Endo III glycosylases, or Exo III or Endo IV AP
endonucleases confers a modest resistance to psoralen adducts. With the exception of
Endo IV, these enzymes sensitize cells to both angelicin and 8-methoxypsoralen.
Further, we show that the absence of these enzymes did not detectably affect the rate that
interstrand cross-links were incised or induced. However, their absence did reduce the
rate that monoadducts appeared during UVA-irradiation. Taken together, the results are
most consistent with the idea that the base excision repair enzymes sensitize cells to
psoralen agents, by impeding the formation or repair of the monoadduct species. The
glycosylases did not appear to contribute to survival, excision, or repair of the interstrand
cross-links in vivo.
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Introduction
DNA interstrand cross-links are a form of damage that covalently link
complementary strands of DNA. Chemical agents that form cross-links are highly toxic
and are widely used to treat cancer, vitiligo, and psoriasis (1) (2–4). Interstrand-crosslinks prevent the separation of the two DNA strands and therefore represent an absolute
block to the essential processes of replication and transcription, and is thought to be the
primary cause of lethality in cells (5, 6). Psoralens—tricyclic compounds comprised of
furan and pyrone rings—intercalate DNA to form noncovalent bonds. At 5'-TA
sequences, absorption of UVA light results in a covalent bond between the furan or
pyrone ring and thymine. If the furan-side monoadduct absorbs a second photon, covalent
linkage between the remaining pyrone ring can occur with a second pyrimidine, resulting
in a DNA interstrand cross-link (7, 8). Thus, psoralen-induced damage creates both
monoadducts and DNA interstrand cross-links. However, based on studies using
compounds or conditions that preferentially generate a single form of damage, disruption
of metabolic processes and lethality is thought to result almost entirely from the crosslink product (6, 9, 10). The harmful nature of cross-link damage and the effective use of
cross-linking agents in treating skin disease and some form of cancers has led to an
interest in how these lesions are processed in cells.
The mechanism by which these lesions are repaired has been a challenge to
address. In the case of monoadducts, the nucleotide excision repair pathway excises the
damaged region of DNA and the complementary, undamaged strand can be used as a
template to restore the excised region. Alternatively, in the case of the cross-links the
adduct remains attached to the complementary strand following excision, preventing the
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completion of faithful repair. To address this, several models have been proposed for the
repair of interstrand cross-links, each involving the combined action of several repair
pathways acting sequentially. Most models propose that repair is initiated by nucleotide
excision repair-catalyzed excision, and that either recombination or translesion synthesis
then acts to restores the template of the incised region(11–14). In theory, a second round
of nucleotide excision repair would then be able to complete the repair process. Other
models suggest that incisions by nucleotide excision repair of both strands may lead to
breaks that require double strand break repair pathways (15–17).
Despite these models, there is little evidence to support the idea that these
pathways contribute to survival in the presence of interstrand cross-links exclusively.
Nucleotide excision repair appears to recognize and incise cross-links both in vivo and in
vitro (13, 18). However, in Chapter II of this manuscript we show that other nucleotide
excision repair mutants, such as uvrD, fail to incise interstrand cross-links in vivo but
remain nearly as resistant as wild type cells to interstrand cross-links. Similarly, mutants
lacking translesion polymerases, or impaired for double strand break repair are no more
hypersensitive to cross-linking agents than agents producing monoadducts alone, arguing
that these pathways do not significantly contribute to survival in the presence of crosslinks. Furthermore, we also showed through direct calculations of a lethal dose of
interstrand cross-links in E. coli that as few as 1 cross-link is sufficient to inactivate cells.
Thus, it is possible that each of these pathways attempts to process these lesions but that
their complexity prevents successful repair in cells and that multiple repair pathways
cannot effectively operate sequentially as proposed in most models. While these
observations may argue against an efficient mechanism for interstrand cross-link repair,
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in humans cancer cells are known to develop resistance to cross-link based
chemotherapeutics (19–21). This suggests the possibility that the normal repair pathways
that interact inadequately with cross-links can be altered to process these lesions and
therefore characterization of the mechanisms involved in typical interactions with crosslinked DNA is of importance.
Base excision repair is one pathway that has recently garnered interest for its
potential effects on cross-link repair. There are conflicting reports as to the overall role
of base excision repair in cross-link survival, with studies mostly in vertebrates
suggesting that it can either promote or hinder repair. Early studies proposed that a
glycosylase acting to detach a cross-link from a substrate such as a stalled replication fork
would represent a less dangerous lesion for the cell, as it would avoid an early break of
the DNA backbone (22). In support of this, 3-methyladenine DNA glycosylase (Aag) was
shown to protect against the clastogenic effects of MMC in murine embryonic stem cells,
improving cell survival and decreasing sister chromatid exchanges(23). However, the
same study found no effect when nitrogen mustard was used as a cross-linking agent,
suggesting that the repair process was agent-specific. Couvé et al. showed that purified
Endo-VIII-like protein, NEIL1, was capable of incising psoralen-induced monoadducts
from oligonucleotide duplexes, but not cross-links (24), leading the authors to speculate
that base excision repair proteins may act at a late step in the repair pathway. They later
confirmed that NEIL1 could initiate repair of psoralen cross-links on substrates
mimicking those encountered during the second round of incisions on synthetic substrates
in vitro and that mutations in this gene product sensitized cells to psoralen (25). In nonsmall cell lung cancer cells, overexpression of APE1—the human apurinic/apyrimidinic
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endonuclease—has been correlated cisplatin resistance, a cross-linking agent commonly
used in chemotherapy (26). This would seem to imply that APE1 protects against
lethality from cross-links.
Other studies suggest base excision repair impairs survival in the presence of
cross-links. Loss of uracil DNA glycosylase (UNG) in primary mouse embryonic
fibroblasts has been reported to confer cisplatin resistance (27). The authors demonstrated
that, in vitro, cisplatin cross-links could lead to the preferential deamination of
surrounding cytosines and that UNG may lead to detrimental breaks at these locations.
McNeill et al. demonstrated that NEIL1 binds to trioxsalen cross-link substrates in vitro
and that in LN428 cells NEIL1 slows recruitment of XPC, a protein required for global
nucleotide excision repair (28). Finally, using Xenopus egg extracts, NEIL3 glycosylase
has been found to be capable of incising psoralen but not cisplatin DNA cross-links on
plasmids substrates (29). The authors propose that this may represent a mechanism that
promotes repair of psoralen cross-links, however whether NEIL3 operates in this manner
in vivo has not been examined. In vitro, several DNA glycosylases from both prokaryotes
and eukaryotes have been shown to bind and/or incise both psoralen monoadducts and
cross-links (25) (28, 30) (29) (31). However, it is not clear whether these gene products
act explicitly on cross-links or monoadducts in vivo.
Identifying genes that specifically process or affect survival of interstrand crosslinks has remained a challenge because all cross-linking agents induce multiple forms of
damage (32–34) and most mutants that have been identified as hypersensitive to crosslinking agents are also hypersensitive to chemicals producing monoadducts (9), making it
difficult to attribute the mutant's hypersensitivity to the cross-link. Therefore, to
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differentiate and identify gene products that are specifically involved in processing crosslinks, monoadducts, cross-links, or both, we compared the survival of E. coli cultures
irradiated with UVA in the presence of 8-methoxypsoralen or angelicin. The comparison
between 8-methoxypsoralen and angelicin allowed us to differentiate between genes that
are involved in the general repair of monoadducts from those that may have a specific
role in interstrand cross-link repair (35). 8-methoxypsoralen forms DNA monoadducts
and interstrand cross-links at different ratios depending on concentration of drug, dose of
UVA light, and cell line (36) (37–39). Angelicin is a congener of psoralen whose angular
structure renders its unable to form cross-links, producing almost entirely monoadducts
(11, 40, 41) (42). Thus, the survival of mutants lacking gene products specific to
processing interstrand cross-links would be expected to be distinct between 8methoxypsoralen and angelicin relative to wild type cultures. Here, we characterized
several base excision repair mutants that have been proposed to be involved in psoralen
cross-link processing based on previous biochemical studies in bacteria or their
mammalian homologs.

Methods
Bacterial Strains. The parent strain used in this study is SR108, a thyA36 deoC2
derivative of W3110(43, 44). Isogenic strains lacking uvrA (HL952), nei (CL1005), nth
(CL1006), fpg (CL1009), and fpg nth nei (CL1938) were constructed using standard P1
transduction methods and have been described previously (45, 46). Isogenic strains
lacking nfo (CL1116) and nfi (CL1326) were made by standard P1 transduction of the
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nfo-1::kan marker from BW540 and nfi-1::cat marker from BW1171 into SR108,
respectively (47) (48).
CL1155 (DY329 xth::cat) was constructed using the recombineering strain
DY329 (49). The chloramphenicol resistance gene was amplified from TP507 (50) using
PCR primers xthF-catF,
5’gtctcttttaatatcaacggcctgcgcgccagacctcacTGTGACGGAAGATCACTTCG, and xthRcatR, 5’cggtttttccatgctgcggatttcatagtcgatgccggtACCAGCAATAGACATAAGCG. The
PCR product was then transformed into DY329 to generate CL1155, selecting for
chloramphenicol resistance. The gene replacement was transferred into SR108 using
standard P1 transduction to generate the isogenic xth strain used in this study, CL1168.

Psoralen-UVA and Angelicin-UVA Survival Assays. Fresh overnight cultures were diluted
1:100 in 8-mL Davis medium (51) supplemented with 0.4% glucose, 0.2% Casamino
Acids, and 10 µg/mL thymine (DGCthy) and grown at 37°C to an optical density of 0.4 at
600 nm (OD600). At this time, 10 µg/mL of 8-methoxypsoralen or 40 µg/mL of angelicin
was added to the cultures and incubation continued for 10 min. Angelicin-treated cells
were UVA-irradiated for longer time increments than 8-methoxypsoralen-treated cells in
order to achieve comparable kill curves for wild type cells in either condition. Cells were
then irradiated using two 32-watt UVA bulbs (Sylvania) with a peak emittance of 320 nm
at an incident dose of 6.3 J/m2/s. At the times indicated, 100-µL aliquots were removed
from each culture and serially diluted in 10-fold increments. Triplicate 10-µl aliquots of
each dilution were spotted onto Luria-Bertani agar plates supplemented with 10 µg/mL
thymine (LBthy) and incubated at 37°C. Viable colonies were counted the next day to
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determine the surviving fraction. 8-methoxypsoralen was purchased from Acros
Organics (item 298-81-7, lot A0143457). Angelicin was purchased from Sigma-Aldrich
(item A0956, lot 042M4054V).

In vivo detection of DNA interstrand cross-links. Cultures containing the plasmid
pBR322 were grown overnight at 37°C in DGCthy medium supplemented with 50 µg/mL
of ampicillin. A 0.1-mL aliquot from this culture was pelleted and resuspended in 10-mL
DGCthy medium without ampicillin and grown in a 37°C shaking water bath to an
OD600 of 0.4. At this time, cultures used for the incision/recovery assay were exposed to
20 µg/mL 8-methoxypsoralen for 10 min at 37°C and subsequently irradiated with a
UVA dose of 5.7 kJ/m2. Irradiated cultures were then incubated for a recovery period of
120 min where 0.75-mL aliquots were collected at times indicated and then transferred to
an equal volume of ice-cold 2X NET buffer (10mM Tris [pH 8.0], 40mM EDTA [pH
8.0], 400mM NaCl). Cells were pelleted, resuspended in 130-µL lysis buffer (1 mg/ml
lysozyme, 0.5 mg/mL RNaseA in 10 mM Tris, 1 mM EDTA [pH 8.0]), and incubated at
37°C for 30 min. Then, 10-uL of 10 mg/mL proteinase K and 10-µL of 20% Sarkosyl
were added to the samples, and incubation continued for 1 hour at 37°C. Samples were
extracted with four volumes of phenol-chloroform, followed by two volumes of
chloroform and then dialyzed against 200 ml of 1mM Tris (pH 8.0), 1mM EDTA (pH
8.0) for 45 min using 47-mm Millipore 0.025-µm pore disks. The DNA was digested
with HindIII (Thermo Fisher) overnight at 37°C. Samples were electrophoresed on a
0.75% alkaline agarose gel in 30 mM NaOH, 1 mM EDTA at 1 V/cm for 16 hours. DNA
in the gels was then transferred to Hybond N+ nylon membranes (GE Healthcare) using
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standard Southern blotting techniques. The plasmid DNA was detected by probing with
32

P-labeled pBR322 that was prepared by nick translation (Roche) using alpha32P-dCTP

>6000Ci/mmol (Perkin-Elmer). Southern blots were visualized using a Storm 840
phosphorimager (GE Biosciences) and its associated ImageQuant analysis software.
The fraction of 8-methoxypsoralen cross-links formed at each time point was
calculated as the ratio of DNA running at about twice the molecular weight of the linear
band to the total DNA per lane and normalized to the fraction of cross-links in untreated
samples.

Fraction of cross-linked plasmid = (XDtime(x)/TDtime(x)) - (XDuntreated/TDuntreated), where XD
represents cross-linked DNA and TD represents total DNA.

Results
To examine how base excision repair affects survival in the presence of 8methoxypsoralen-induced DNA interstrand cross-links, we compared the survival of
several glycosylase mutants following UVA irradiation in the presence of either 40
µg/mL angelicin or 10 µg/mL 8-methoxypsoralen. In previous work, these concentrations
of have been shown to form adducts in DNA at similar frequencies for a given dose of
UVA (40, 52). Angelicin plus ~20 kJ/m2 UVA irradiation reduced survival of wild type
cells by more than four orders of magnitude (Figure 3.1A). By comparison, in the
presence of 8-methoxypsoralen, a similar loss of viability was observed within 4 kJ/m2,
with lethality (LD37) occurring at ~1.8 kJ/m2. In Chapter II, we show that this dose
represents only about 1 cross-link per chromosome, consistent with cross-links being
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highly lethal lesions that lack an efficient mechanism of repair (53). In mutants lacking
either Endo V (nfi) or Endo VIII (nei), we found that the survival was similar to that of
wild type cells in the presence of either angelicin or 8-methoxypsoralen (Figure
3.1A&B), arguing against a role for these enzymes in processing psoralen-induced
damage. By comparison, in the absence of either Fapy (fpg) or Endo III (nth), cultures
were modestly more resistant to UVA irradiation in the presence of either angelicin or 8methoxypsoralen compared to wild type cells (Figure 3.1). The resistance conferred by
deletion of fpg or nth in the presence of monoadducts was similar in magnitude to that
seen with when both monoadducts and cross-links were present, arguing that these
glycosylases are likely to sensitize cells to psoralen through interactions with the
monoadducts, rather than cross-links.
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Figure 3.1. Glycosylases Nei and Fpg and endonucleases Nfi and Nth are not required
for 8-methoxysproalen-induced interstrand cross-link survival in E. coli. The survival of
WT (closed squares), nei-(closed triangles), fpg-(open diamonds), nfi-(closed circles),
and nth-(open circles)deficient cells following UVA irradiation in the presence of A) 40
µg/mL angelicin or B) 10 µg/mL 8-methoxypsoralen. Angelicin produces monoadducts
based on its angular structure (depicted above A) whereas 8-methoxypsoralen can
produce both monoadducts and DNA interstrand cross-links due to its linear structure
(depicted above B). Graphs represent an average of at least 3 experiments. Error bars
represent standard error of the mean.
Following binding and incisions by DNA glycosylases, the next step in base
excision repair is carried out by AP endonucleases, which are required to incise the DNA
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backbone and release the bound glycosylases from the lesion (54, 55). E. coli has two
AP endonucleases, Exo III and Endo IV, encoded by xth and nfo, respectively (48).
Similar to that seen in fpg and nth mutants, deletion of xth conferred a modest resistance
to both angelicin and 8-methoxypsoralen-damage (Figure 3.2). By comparison, although
inactivation of nfo did not affect the survival in in the presence of angelicin, it conferred a
modest resistance that was specific to 8-methoxypsoralen-treatement. These observations
suggest that base excision repair gylcosylases and AP endonucleases modestly sensitize
cells to psoralen-induced damage. With the exception of Endo IV, a similar sensitization
was observed in the presence of either angelicin or 8-methoxypsoralen, suggesting that
the pathway is acting upon the monoadduct product and not interstrand cross-links. In
the case of Endo IV, the data could suggest that the enzyme is specific for interacting
with interstrand cross-links or that it may distinguish between angelicin and 8methoxypsoralen structures, thus only recognizing the 8-methoxypsoralen monoadduct.
Considering that all other enzymes appear to operate on the monoadduct, we favor the
latter interpretation, but cannot exclude the possibility that Endo IV is uniquely
recognizing interstrand cross-links.
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Figure 3.2. Inactivation of Endonuclease IV confers resistance to 8-methoxypsoraleninduced damage. The survival of WT (closed squares), xth-(open squares), and nfo-(open
triangles) deficient cells following UVA irradiation in the presence of A) 40 µg/mL
angelicin or B) 10 µg/mL 8-methoxypsoralen. Anglicin produces monoadducts whereas
8-methoxypsoralen produces monoadducts and DNA interstrand cross-links. Graphs
represent an average of at least 3 experiments. Error bars represent standard error of the
mean.
To further characterize whether base excision repair's mode of action was
centered on the monoadduct or interstrand cross-link, we examined how the enzyme's
presence affected the rate that these lesions were formed and incised. We reasoned that if
the base excision repair enzymes impede cross-link removal, then mutants lacking the
glycosylases or AP endonucleases may incise these lesions are a faster rate. To examine
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the rate of cross-link incision, cultures containing plasmid pBR322 were irradiated with
UVA in the presence of 8-methoxypsoralen and then allowed to recover. At various times
during the two-hour recovery period aliquots of each culture were collected and total
genomic and plasmid DNA was purified then restricted with HindIII to linearize the
plasmid. The form of the plasmid DNA was determined by Southern analysis following
alkali denaturing agarose electrophoresis. Under denaturing conditions, DNA molecules
that contain DNA interstrand cross-links are prevented from separating and can be
detected due to their slower migration pattern relative to linear, single-stranded DNA (56,
57). In wild type cells, over 80% of the cross-links were incised by the end of the twohour recovery period (Figure 3.3). By contrast, in uvrA mutants the rate of incision was
severely impaired, with the majority of cross-links remaining unincised throughout the
recovery period. When we examined a mutant lacking the fpg, nth, and nei glycosylases,
the rate of cross-link incision was not detectably different than that seen in wild type
cells. Similarly, in cultures lacking either the Exo III or Endo IV AP endonuclease, the
rate of cross-link incision was similar to that seen in wild type cells. Thus, the absence of
these base excision repair gene products does not alter the rate of cross-link incision.
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Figure 3.3. Inactivation of glycosylases or AP endonuclease activity does not alter
incision rate of 8-methoxypsoralen cross-links from E. coli cells containing plasmid
pBR322. A) Cultures containing pBR322 were UVA irradiated with 5.7 kJ/m2 in the
presence of 20 µg/mL of 8-methoxypsoralen and then allowed to recover for 120
minutes. To examine the cross-links remaining at time points during the recovery period,
total genomic and plasmid DNA was purified from cells, restricted with HindIII to
linearize the plasmid, and examined by Southern analysis following alkali gel
electrophoresis using 32P-labeled pBR322 as a probe. B) The fraction of cross-links
remaining in the DNA during the recovery period is plotted for WT (filled squares), uvrA
(filled diamonds), fpg nth nei (open squares with X), nfo (open triangles), and xth (open
squares). The initial percentage of cross-linked plasmids immediately following UVA
irradiation (time 0) were WT 4.2% ± 0.7; uvrA 4.4% ± 0.5; fpg nth nei 3.0% ± 0.1; nfo
4.5% ± 0.1; xth 4.5% ± 0.3.
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In addition to the rate of cross-link incision, we also monitored and compared the
rate that cross-links were formed in wild type, excision defective uvrA, the fpg nth nei
glycosylase mutant, and AP endonuclease mutant nfo. To this end, cultures containing the
plasmid pBR322 were UVA-irradiated in the presence of 8-methoxypsoralen for
increasing amounts of time. Total DNA was purified from treated cultures at times
indicated, linearized with HindIII, and examined by Southern analysis following alkali
agarose gel electrophoresis. In wild type cultures, the amount of interstrand cross-links
increased with time of irradiation with ~10% of the plasmids containing a cross-link
following 34 kJ/m2 UVA (Figure 3.4). By comparison, in uvrA mutants an elevated level
of cross-links was observed at each UVA dose relative to wild type cultures, consistent
with the idea that neither the monoadducts nor cross-links can be removed or incised,
respectively, in these mutants. Cultures lacking Fapy, Endo III, and Endo VIII
glycosylases displayed a rate of cross-link induction that was similar to that of wild type
cells.
We also noted that in the absence of the glycosylases, a unique intermediate
appeared which migrated progressively faster than the single cross-link product as the
UVA dose increased. At present, we are unable to identify this intermediate. However, in
previous work, we’ve noted a similar progressively increasing mobility of the cross-link
band occurring at high UVA doses, after the entire population of plasmids has been
cross-linked. We attributed this increased mobility to plasmids containing multiple crosslinks, which would limit the ability of the arms to denature, resulting in a plasmid having
a more linear, faster migrating shape. Although the mobility is similar here, it is not clear
why multiple cross-links would form only on a subset of the plasmids. Further, this effect
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appears to only occur in the glycosylase mutants. Since the effect is not observed in the
nfo-mutant, which is also hyperresistant to psoralen-induced damage, we think the multicross-linked species or intermediate is unlikely to be responsible for the hyperresistance
of the glycosylase mutant.
A second possibility is that this accumulating band shift represents a repair
intermediate. A single incision of one strand may also produce a smaller product that
migrates faster. However, this observation is not consistent with the observation that the
species appears to progressively migrate faster as the dose increases. Further, since this
intermediate does not appear in wild type cells or in nfo-mutants—which are also
hyperresistant—it seems unlikely that it represents a true ‘repair’ intermediate.
In the AP endonuclease mutant, nfo, the rate of cross-link formation is also
similar to that of wild type cells. The lack of effect in glycosylase incision or formation is
interesting considering that the mutant as resistant to psoralen- but not angelicin-induced
damage. The lack in difference of activity towards cross-links supports the idea that Endo
IV operates on the monoadduct form of psoralen-induced damage.
Directly monitoring the removal or induction of monoadducts in vivo is more
challenging than that of cross-links. Although we were not able to determine the number
of monoadducts present in each plasmid molecule, the accumulation of monoadducts
does appear to modestly retard the mobility of the linear plasmid. This is most apparent in
the uvrA-mutant, where the linear plasmid band progressively shifts up as the UVA dose
increases and more monoadducts form on the DNA molecule. In wild type cells, a similar
but less prominent shift of the linear DNA occurs as UVA dose increases, likely
reflecting the ability to remove the lesions during the period of irradiation, which occurs
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over a 90-minute period (Figure 3.4A). By comparison, however, no noticeable shift
occurred in either the nfo- or fpg nth nei-deficient cultures, suggesting that fewer
monoadducts were forming in these mutants at each dose of UVA. In Figure 3.4C we
quantified the decrease of the initial linear band area per UVA dose over total DNA per
lane.
fpg nth nei-deficient cultures appeared to accumulate total damage at a slower rate
than wild type cells (Figure 3.4C). Although we are unable to quantify the number of
monoadducts required to shift the linear band, a slower rate of monoadduct formation in
these base excision repair mutants could explain the modest resistance observed to both
angelicin and psoralen in these mutants and suggests that the presence of these enzymes
may impede monoadduct removal.
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Figure 3.4. Cross-link induction in base excision repair mutants is similar to induction in
wild type cells. A) Dose response of interstrand cross-links formation in vivo. Wild type,
uvrA-, fpg nth nei-, and nfo-deficient cultures containing plasmid pBR322 were exposed
to increasing doses of UVA light in the presence of 10µg/mL 8-methoxypsoralen. DNA
from cultures was purified and analyzed as in Figure 3 to observe interstrand cross-link
formation at each dose indicated. B) The percent of cross-linked plasmid (4.3 kB) at each
dose is plotted per strain: WT (filled squares), uvrA (filled diamonds), fpg nth nei (open
squares with X), and nfo (open diamonds). C) The percent linear DNA at ease dose is
plotted per strain.
Discussion
Here we show that glycosylase mutants fpg and nth and AP endonuclease mutant
xth are modestly resistant in the presence of angelicin monoadducts as well as 8-

66
methoxypsoralen monoadducts and cross-links compared to wild type cells. Since the
mutants are about equally as resistant to either chemical plus UVA light, we infer that the
sensitivity observed in presence of these gene products was due to their detrimental
interaction with monoadducts, not cross-links. Alternatively, AP endonuclease mutant nfo
was specifically resistant to 8-methoxypsoralen cross-links and monoadducts, which
could mean that either the functional protein operates specifically, albeit negatively, with
cross-links or that it interacts with 8-methoxypsoralen monoadducts but not angelicin
monoadducts due to difference in isomer structure. Purified Fpg and Nei have both been
shown to bind and incise monoadducts as well as an unhooked three-stranded diadduct in
vitro (25). However, we found that neither the glycosylases or AP endonucleases altered
the rate of cross-link incision or formation in vivo. The resistance of these mutants and
the lack of effect on the incision rate argue against the idea that these enzymes promote
repair of cross-links in cells. These observations, coupled with the resistance seen in
angelicin-treated cells, support the interpretation that base excision repair proteins might
interact specifically with monoadducted DNA.
Other observations that support the idea that base excision repair proteins operate
on psoralen monoadducts can be seen in the dose curve blots of wild type, nfo-, and uvrAdeficient cells where the linear band slowly migrates upward as UVA increases (Figure
4A). This is more prevalent in the uvrA mutants, presumably because monoadducts are
not incised in this strain and would cause denatured DNA to run slightly slower than
damage-free single stranded DNA. Because this is seen in wild type cells but not in triple
glycosylase mutants, we would propose that when these proteins are present they interact
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with monoadduct DNA and obstruct other repair enzymes, such as those in the nucleotide
excision repair pathway, from gaining access to the lesions to effect removal.
Cross-link formation by 8-methoxypsoralen and UVA light occurs in a sequence
of steps where a molecule intercalates DNA, undergoes photoactivation of the furan ring
with a thymine base, and then undergoes a second photoactivation of the pyrone ring with
an adjacent thymine. Monoadducts that occur on the pyrone ring are not precursors for
cross-linking (36, 59). As previously mentioned, Couvé et al. demonstrated that Fpg and
Nei glycosylases are capable of excising psoralen monoadducts (24) as well as unhooked
three-stranded diadducted oligos (25), however the substrates that these studies focused
on were of 8-methoxypsoralen covalently bound to DNA from the molecule’s pyrone
ring. If it were the case that one the base excision repair proteins examined here operate
explicitly on pyrone-side adducts, then it would make sense why we did not observe a
difference in cross-link formation in the glycosylase mutants. This is because this form of
damage cannot be converted into a cross-link and therefore its repair would not slow
down cross-link formation in either wild type or glycosylase-deficient cells. If these
enzymes do operate to remove pyrone-side monoadducts in a manner that impedes
another pathway from processing them more pragmatically, then this would agree with
our observation that mutants survive angelicin or 8-methoxytreatment better than wild
type cells.
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Chapter IV: Conclusion

DNA interstrand cross-links are a highly disruptive form of damage in cells that
induce lethality if not repaired (1). The mechanisms of repair have been challenging to
study but are extremely important to understand when considering the development of
new cross-link-based chemotherapeutics (2)(3). Additionally, characterizing the cellular
pathways involved in DNA interstrand cross-link repair could benefit future treatment of
patients with Fanconi anemia (4). Early cross-link repair studies in E. coli demonstrated
that these lesions were incised from DNA in repair proficient cells but not in strains with
defective nucleotide excision repair enzymes (5). Experiments have since been conducted
in a variety of model systems such as yeast, Drosophila, Xenopus, and mammalian cells
which all have shared repair mechanisms for removing cross-links but each differ in
complexity of the pathways involved (6). Mammalian model systems have suggested the
involvement of numerous FANC proteins—those associated with the Fanconi anemia
pathway—as well as enzymes from multiple repair pathways but delineating the overall
process has proven challenging to recapitulate in vivo (7) (8). Therefore, the aim of this
study was to provide in vivo evidence for cross-link repair following the initial incision
steps by nucleotide excision repair by returning to experiments in E. coli—a simplified
model organism with highly conserved repair pathways.
In order to accomplish this, E. coli cultures deficient in candidate repair genes
were examined for their sensitivity to 8-methoxypsoralen+UVA-induced cross-links and
survival capacity relative to wild type cells. Because 8-methoxypsoralen-UVA treatment
also induces single-stranded damage, the monofunctional isomer angelicin was used to
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compare sensitivity of mutant strains to damage induced by either chemical (9). First,
candidates from the nucleotide excision repair pathway were examined to determine if
the uvrD gene product would contribute to survival of cross-links. The observation that a
uvrD mutant was nearly as resistant to 8-methoxypsoralen treatment as wild type cells
but nearly as sensitive to angelicin treatment as uvrA mutants suggested that when
present, the UvrD enzyme only contributes to the repair of monoadducts. To confirm this,
the incision of cross-links from endogenous plasmids was examined via Southern blot
analysis following UVA irradiation in the presence of 8-methoxypsoralen in wild type,
uvrA-, and uvrD-deficient strains. Surprisingly, uvrD mutants have an impaired capacity
for incising cross-links, just like uvrA mutants. This observation seemed to conflict with
the survival results raising the question of how a uvrD mutant could survive similar to
wild type cells while having a diminished to almost negligible capacity for incising crosslinks from endogenous plasmid DNA.
In order to resolve this conflict, an additional Southern blot analysis was
performed to examine the rate of cross-link formation and from this determine the
number of cross-links capable of inducing lethality in wild type cultures. It was observed
that one cross-link per E. coli chromosome is sufficient to inactivate wild type cell
cultures. This quantity is lower than previously reported but comports with our
observations that nucleotide excision repair enzymes may be necessary to incise crosslinks but that this processing event does not contribute to survival in E. coli. Additionally,
we show via survival analysis that double-strand breaks are not a predominant
intermediate in cross-link repair and that translesion synthesis does not contribute to
survival of cross-links. Evidence for this was that recN mutants and polBdinBumuDC
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mutants are equally sensitive to UVA irradiation in the presence of angelicin or 8methoxypsoralen.
The final candidate pathway that was examined in this study was base excision
repair. Glycosylase mutants—fpg, nth, nfi, and nei—were examined as well as
apurinic/apyrimidinic (AP) endonuclease mutants—xth and nfo—for their sensitivity to
psoralen treatments. While none of these mutants exhibited any sensitivity relative to
wild type cells, fpg, nth, and xth mutants exhibited resistance to both isomers of psoralen,
suggesting that when these gene products are present they sensitize cells through
interactions with monoadducts, not cross-links. Additionally, cells deficient in AP
endonuclease Endo IV (nfo) exhibited resistance exclusively to UVA irradiation in the
presence of 8-methoxypsoralen treatment. Southern blot analysis was performed to
determine if this resistance was specific to cross-links or just the linear monoadduct
structure of this isomer by examining if the rate of cross-link incisions was enhanced in
the resistant mutants or if cross-links formed more slowly. In either case, mutants
exhibited phenotypes that were indistinguishable from wild type cells. However, what did
slightly differ in the dose curve blots was that the shift of linear, undamaged DNA was
slower in triple glycosylase mutant—fpgnthnei—suggesting that the formation of
monoadducts may be impeded when these gene products are absent. Additionally, a DNA
intermediate was observed from this mutant that migrated just below the cross-link band
and seemed to accumulate as UVA dose increased.
Although we were unable to characterize this intermediate, we infer that the
structure either represents the accumulation of more cross-links or that it is an incision
byproduct on a plasmid molecule that contains at least one cross-link. The latter seems
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more reasonable since these mutants are associated with a greater capacity for survival
relative to wild type cells. Furthermore, it would support the argument that the
glycosylases operate on monoadduct structures and impede their removal by other repair
pathways such as nucleotide excision repair. In summary, although cross-links are
capable of being processed in wild type cells, the observation that one cross-link is
sufficient for reducing survival of cell in cultures to 37% suggests that the repair enzymes
involved are not capable of restoring the integrity of the DNA following damage in E.
coli. The results that support these conclusions are summarized in Table 4.1.
Table 4.1 Summary of in vivo results of E. coli mutants from candidate DNA interstrand
cross-link repair pathways relative to wild type cells.
Results relative to wild type cells
Survival analysis
Candidate
repair
pathway
Nucleotide
Excision Repair
Translesion
Synthesis
Double-strand
Break Repair

Base Excision
Repair

Southern blot analysis

8-methoxypsoralen
+ UVA

Cross-link
incision
rate

Cross-link
induction
rate

sensitive

sensitive

impaired

enhanced

sensitive

equal to WT

impaired

-

mildly
sensitive

mildly
sensitive

-

-

sensitive
mildly
sensitive
resistant

-

-

-

-

fpg-

sensitive
mildly
sensitive
resistant

nth-

resistant

resistant

nei-

equal to WT

equal to WT

equal to
WT*

equal to
WT*w

nfi-

equal to WT

equal to WT

-

-

xth-

resistant

resistant

equal to WT

-

nfo-

equal to WT

resistant

equal to WT

equal to WT

Mutant
examined

Angelicin
+ UVA

uvrAuvrDpolBdinBumuDCrecArecN-

*

triple mutant of fpg, nth, & nei was examined

w

similar, with the exception of an unusal DNA intermediate

How these findings may relate to more complex organisms such as mammals has
not been addressed directly in the present study but is not unimaginable since the repair
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pathways examined here are highly conserved across taxa. In humans, chromosomal
abnormalities as observed by chromosomal breakage tests in Fanconi anemia blood
samples indicate a clear difference between cross-link processing in these cells versus
blood samples from non-afflicted persons (10). This does not contradict our inferences of
minimal repair capacity in wild type cells but simply suggests that lack of repair capacity
in Fanconi cells is far more destructive to replicated chromosomal structures than when
cross-linking are processed, especially during replication. Furthermore, since the E. coli
genome is ~700 times smaller than the human genome and is comprised mostly of geneencoding DNA it seems reasonable that human cells would have a higher capacity for
damage from cross-links.
In summary, cross-links are highly lethal in E. coli and processing events appear
to be non-productive in the traditional sense of eliciting a faithful repair mechanism.
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